DrugPatentWatch Database Preview
Antares Pharma Inc Company Profile
What is the competitive landscape for ANTARES PHARMA INC, and when can generic versions of ANTARES PHARMA INC drugs launch?
ANTARES PHARMA INC has three approved drugs.
There are sixteen US patents protecting ANTARES PHARMA INC drugs.
There are fifty-five patent family members on ANTARES PHARMA INC drugs in twelve countries.
Summary for Antares Pharma Inc
| International Patents: | 55 |
| US Patents: | 16 |
| Tradenames: | 4 |
| Ingredients: | 3 |
| NDAs: | 3 |
| Patent Litigation for Antares Pharma Inc: | See patent lawsuits for Antares Pharma Inc |
Drugs and US Patents for Antares Pharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antares Pharma Inc | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-003 | Oct 11, 2013 | RX | Yes | Yes | 7,776,015 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Antares Pharma Inc | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-007 | Mar 24, 2016 | RX | Yes | Yes | RE44847 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Antares Pharma Inc | OTREXUP PFS | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-012 | May 31, 2017 | DISCN | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Antares Pharma Inc | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-001 | Oct 11, 2013 | RX | Yes | Yes | 8,562,564 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-001 | Sep 28, 2018 | RX | Yes | Yes | 8,562,564 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Antares Pharma Inc | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-008 | Mar 24, 2016 | RX | Yes | Yes | 8,945,063 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Antares Pharma Inc | OTREXUP | methotrexate | SOLUTION;SUBCUTANEOUS | 204824-002 | Oct 11, 2013 | RX | Yes | Yes | RE44847 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Antares Pharma Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| China | 102612381 | ➤ Try a Free Trial |
| European Patent Office | 1850892 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 2013012745 | ➤ Try a Free Trial |
| Japan | 4299466 | ➤ Try a Free Trial |
| European Patent Office | 2731645 | ➤ Try a Free Trial |
| South Korea | 20140050663 | ➤ Try a Free Trial |
| Japan | 5968976 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
